GE HealthCare earnings rose in the third quarter of 2026, and the medical technology company raised its full-year outlook for adjusted profit and organic revenue growth. Its shares gained 7.39% to $76.36 in Nasdaq morning trading on October 28.

Key Takeaways

  • Third-quarter revenue rose 7.2% to $5.513 billion, with organic growth across all segments.
  • The company raised its 2026 adjusted earnings forecast to $4.95–$5.05 per share.
  • Neal Sandy will take over as head of Patient Care Solutions on November 16.

GE HealthCare earnings and revenue

Net income attributable to GE HealthCare increased to $615 million, or $1.36 per share, from $446 million, or $0.98 per share, in the third quarter of 2025. Adjusted earnings were $608 million, or $1.34 per share, compared with $1.07 per share a year earlier.

Revenue increased from $5.143 billion a year earlier. Organic revenue growth was 6.2%, while total orders rose 4.0% organically. Backlog stood at $23.7 billion.

Adjusted earnings before interest and taxes, or EBIT, rose to $913 million from $761 million. The adjusted EBIT margin expanded to 16.6% from 14.8%. The company attributed the improvement to volume, pricing, cost productivity and a favorable year-over-year net tariff impact, partly offset by inflation.

ItemDetails
2026 adjusted earnings per shareNew: $4.95–$5.05; previous: $4.80–$5.00
2026 adjusted EBIT marginNew: 15.5%–15.7%; previous: 15.4%–15.7%
2026 organic revenue growthNew: around 4.0%; previous: 3.0%–4.0%

Full-year guidance moves higher

For fiscal 2026, GE HealthCare now expects adjusted earnings of $4.95 to $5.05 per share, up from its previous forecast of $4.80 to $5.00. The revised range implies growth of 7.9% to 10.1% from 2025 adjusted earnings of $4.59 per share.

The company also raised the lower end of its adjusted EBIT margin forecast and now expects organic revenue growth of around 4.0%, compared with its previous range of 3.0% to 4.0%. CEO Peter Arduini cited improved year-to-date performance and business momentum when announcing the revised guidance.

Patient care leadership change

Jeannette Bankes, president and CEO of Patient Care Solutions, is leaving for a CEO role at another company. Neal Sandy, currently head of product strategy and management for the business, will assume her role on November 16.

The company’s patient care solutions portfolio includes patient monitoring and anesthesia delivery products.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.